ELATIVE long-term open label extension trial demonstrate sustained biochemical response, stabilization of fibrosis markers ...

Bybit, the world's second-largest cryptocurrency exchange by trading volume, is pleased to introduce the Alpha Referral program, enabling users to earn up to 30% commission on trading fees generated ...

Gilead Sciences, Inc. today announced the Phase 3 ASCENT-07 study investigating Trodelvy® (sacituzumab govitecan-hziy) versus chemotherapy as a first-line treatment post-endocrine therapy in ...

Financial Overview - Third Quarter Revenues of $165 Million, Down 41% From a Record a Year AgoAdjusted Pre-Tax Income of $20 Million, GAAP Pre-Tax Income of $12 MillionAdjusted EPS of $0.13; GAAP Dilu ...